Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Delvys Rodriguez Abreu"'
Autor:
Michael Boyer, Rina Hui, Damien Urban, Philip Clingan, Wu-Chou Su, Celine Devaux, Shirish Gadgeel, Marina Garassino, Lance Leopold, Jeannie Daniel, Mihaela C. Munteanu, Ayman Samkari, Yiwen Luo, Delvys Rodriguez Abreu
Publikováno v:
BMC Cancer, Vol 23, Iss S1, Pp 1-12 (2024)
Abstract Background The combination of the checkpoint inhibitor (CPI) pembrolizumab and platinum-based chemotherapy is effective frontline therapy for advanced non-small cell lung cancer (NSCLC) lacking targetable mutations. Indoleamine 2,3- dioxygen
Externí odkaz:
https://doaj.org/article/f859d06395444ff68173b8d586898c31
Autor:
Mariano Provencio, Manuel Cobo, Delvys Rodriguez-Abreu, Virginia Calvo, Enric Carcereny, Alexandra Cantero, Reyes Bernabé, Gretel Benitez, Rafael López Castro, Bartomeu Massutí, Edel del Barco, Rosario García Campelo, Maria Guirado, Carlos Camps, Ana Laura Ortega, Jose Luis González Larriba, Alfredo Sánchez, Joaquín Casal, M. Angeles Sala, Oscar Juan-Vidal, Joaquim Bosch-Barrera, Juana Oramas, Manuel Dómine, Jose Manuel Trigo, Remei Blanco, Julia Calzas, Idoia Morilla, Airam Padilla, Joao Pimentao, Pedro A. Sousa, Maria Torrente
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background The survival of patients with lung cancer has substantially increased in the last decade by about 15%. This increase is, basically, due to targeted therapies available for advanced stages and the emergence of immunotherapy itself.
Externí odkaz:
https://doaj.org/article/0111fe9f31fa49208eab155d42059c73
Autor:
Rodolfo Chicas-Sett, Juan Zafra, Delvys Rodriguez-Abreu, Juan Castilla-Martinez, Gretel Benitez, Barbara Salas, Samuel Hernandez, Marta Lloret, Juan Luis Onieva, Isabel Barragan, Pedro C. Lara
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 114:655-665
The percentage of patients with metastatic non-small cell lung cancer (NSCLC) and melanoma who benefit from anti-programmed cell death protein 1 (anti-PD-1) is low owing to resistance mechanisms. SABR has a role in oligoprogressive disease and can im
Autor:
David Carbone, Michael Sharpnack, Kai He, Lisa H. Butterfield, Alexander M. M. Eggermont, Maria Gonzalez-Cao, Niki Karachaliou, Guillermo Crespo, Erika Aldeguer, Ana Drozdowskyj, Ana Giménez-Capitán, Cristina Teixidó, Miguel Angel Molina-Vila, Santiago Viteri Ramírez, Salvador Martin Algarra, Elisabeth Pérez-Ruiz, Iván Márquez-Rodas, Delvys Rodriguez-Abreu, Remei Blanco, Teresa Puértolas, Maria Angeles Royo, Rafael Rosell, Maria Libera Ascierto, Svetlana Hamm, Tanja Wulff, Kerstin Kronthaler, Sabine Schrepfer, Ulrike Parnitzke, Anne Catherine Bretz, Roland Baumgartner, Veronica Ferrucci, Francesco Paolo Pennino, Luisa Dassi, Fatemeh Asadzadeh, Roberto Siciliano, Marianeve Carotenuto, Daniela Spano, Cristina Maria Chiarolla, Adelaide Greco, Monica Cantile, Maurizio Di Bonito, Gerardo Botti, Vandenbussche Jonathan, Gevaert Kris, Massimo Zollo, Teresa Amaral, Ioanna Tampouri, Ulrike Keim, Thomas Eigentler, Claus Garbe, Andrea Forschner, Alessandra Cesano, Sarah Warren, Duane Moogk, Kaitao Li, Zhou Yuan, Shi Zhong, Zhiya Yu, Ivan Liadi, William Rittase, Victoria Fang, Janna Dougherty, Arianne Perez-Garcia, Iman Osman, Navin Varadarajan, Nicholas P. Restifo, Alan Frey, Cheng Zhu, Michelle Krogsgaard, Claire Vanpouille-Box, Silvia C. Formenti, Sandra Demaria, Cristiana Lo Nigro, Alexander Renziehausen, Andreas G. Tzakos, Hexiao Wang, Bhavya Rao, Rubeta Matin, Catherine Harwood, Daniela Vivenza, Federica Tonissi, Marcella Occelli, Lynda Weir, Su Li, Van Ren Sim, Kevin O’Neill, Alan Evans, Alastair Thompson, Peter Szlosarek, Colin Fleming, Charlotte Proby, Nelofer Syed, Marco Merlano, Tim Crook, Robert Ferguson, Danny Simpson, Carlos Martinez, Matjaz Vogelsang, Esther Kazlow, Melissa Wilson, Anna Pavlick, Jeffrey Weber, Ryan Sullivan, Keith Flaherty, Antoni Ribas, Tomas Kirchhoff, Antonio D’Avino, Licia Guida, Augusto Cosacco, Roberta D’Aniello, Piera Maiolino, Teresa Tramontano, Maria R. Sarno, Ida Palazzo, Angela Di Napoli, Gianclaudio Acunzo, Mariarosanna De Fina, Antonia Silvestri, Monica Specchia, Michela Musacchio, Gianfranco Giglio, Francesco Carrozza, Liberato Di Lullo, Gian Marco De Maddi, Adele Venturelli, Elisabetta Gambale, Alessia Gatta, Davide Brocco, Consiglia Carella, Michele De Tursi, Thomas F. Gajewski, Costanza M. Cristiani, Rossana Tallerico, Valeria Ventura, Mariaelena Capone, Gabriele Madonna, Domenico Mallardo, Eliska Selinger, Cinzia Garofalo, Elina Staaf, Ester Simeone, Antonio M. Grimaldi, Genny del Zotto, Elio Gulletta, Gennaro Ciliberto, Alessandro Moretta, Paolo A. Ascierto, Ennio Carbone, Susan Costantini, Angela Sorice, Francesca Capone, Alfredo Budillon, Carolina Cauchi, Grazia Sciancalepore, Michela Rovera, Chiara Varamo, Zelda Seia, Stefania Palazzini, Fabiana Errico, Davide Basso, Laura Quaranta, Giuseppe Forte, Fulvio Lavagna, Silvia Violante, Paolo Bosio, Laura Lattanzio, Marco C Merlano, Mike Gowen, Jeremy Tchack, Hua Zhou, Keith Giles, Scott Paschke, Una Moran, David Fenyo, Aris Tsirigos, Michael Pacold, Silvana Morello, Claudia Sorrentino, Diana Giannarelli, Aldo Pinto, Federica Fratangelo, Rosaria Falcone, Vito Vanella, Dirk Schadendorf, Karl Lewis, Michele Maio, Lev Demidov, Mario Mandalà, Igor Bondarenko, Christopher Herbert, Andrzej Mackiewicz, Piotr Rutkowski, Alexander Guminski, Grant Goodman, Brian Simmons, Chenglin Ye, Gregory Hooper, Matthew J. Wongchenko, Yibing Yan, Frank Hermann, Astrid Ammendola, René Bartz, Bulotta Alessandra, Colombo Letizia, Mirabile Aurora, Lazzari Chiara, Mercuri Santo Raffaele, Parolini Danilo, Rizzo Nathalie, Martella Stefano, Modorati Giulio, Brianti Pina, Cestone Enza, Bellinzona Federica, Miserocchi Elisabetta, Gianni Luca, Gregorc Vanesa, Sanjiv Agarwala, B. Mark Smithers, Axel Haushild, Eric Watcher, Luigi Fattore, Ciro Francesco Ruggiero, Domenico Liguoro, Andrea Cerri, Maria Elena Pisanu, Rita Mancini
Publikováno v:
Journal of Translational Medicine, Vol 16, Iss S1, Pp 1-15 (2018)
Externí odkaz:
https://doaj.org/article/38353f48461f433683ce99cbc35a515e
Autor:
Byoung Chul Cho, Delvys Rodriguez Abreu, Maen Hussein, Manuel Cobo, Anjan J Patel, Nevena Secen, Ki Hyeong Lee, Bartomeu Massuti, Sandrine Hiret, James Chih Hsin Yang, Fabrice Barlesi, Dae Ho Lee, Luis Paz Ares, Robert W Hsieh, Namrata S Patil, Patrick Twomey, Xiaoying Yang, Raymond Meng, Melissa L Johnson
Publikováno v:
The Lancet Oncology. 23:781-792
Targeted inhibition of the PD-L1-PD-1 pathway might be further amplified through combination of PD-1 or PD-L1 inhibitors with novel anti-TIGIT inhibitory immune checkpoint agents, such as tiragolumab. In the CITYSCAPE trial, we aimed to assess the pr
Autor:
Naoyuki Nogami, Mark A. Socinski, Delvys Rodriguez-Abreu, Federico Cappuzzo, Makoto Nishio, Daniil Stroyakovskiy, Anthony Lee, Gene Grant Finley, Geetha Shankar, Tony Mok, Christian Thomas, Robert M. Jotte, Ilze Bara, Shelley Coleman, Fabrice Barlesi, David Merritt, Denis Moro-Sibilot, Wei Yu, Francisco Orlandi, Darren Wan-Teck Lim, Martin Reck, Liza C. Villaruz, Joachim G.J.V. Aerts
Publikováno v:
Journal of Thoracic Oncology, 17(2), 309-323. International Association for the Study of Lung Cancer
JOURNAL OF THORACIC ONCOLOGY
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (2), pp.309-323. ⟨10.1016/j.jtho.2021.09.014⟩
JOURNAL OF THORACIC ONCOLOGY
JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (2), pp.309-323. ⟨10.1016/j.jtho.2021.09.014⟩
Introduction: Final overall survival (OS) analyses are presented for EGFR mutations and liver or brain metastases subgroups in the phase 3 IMpower150 study (NCT02366143) evaluating atezolizumab plus bevacizumab plus carboplatin and paclitaxel (ABCP)
Autor:
Marina C. Garassino, Shirish Gadgeel, Silvia Novello, Balazs Halmos, Enriqueta Felip, Giovanna Speranza, Rina Hui, Edward B. Garon, Hidehito Horinouchi, Shunichi Sugawara, Delvys Rodriguez-Abreu, Martin Reck, Razvan Cristescu, Deepti Aurora-Garg, Andrey Loboda, Jared Lunceford, Julie Kobie, Mark Ayers, Bilal Piperdi, M. Catherine Pietanza, Luis Paz-Ares
Publikováno v:
Scientia
Biomarker; Pembrolizumab; Tissue tumor mutational burden Biomarcador; Pembrolizumab; Càrrega mutacional del tumor tissular Biomarcador; Pembrolizumab; Carga mutacional del tumor tisular Introduction We evaluated tissue tumor mutational burden (tTMB)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8488a9b32fcb55808ebaaf3099381eb9
https://hdl.handle.net/2318/1895736
https://hdl.handle.net/2318/1895736
Autor:
Anthony Lee, Francisco Orlandi, Daniil Stroyakovskiy, Gene Grant Finley, Shelley Coleman, Makoto Nishio, Mark A. Socinski, Christian Thomas, Geetha Shankar, Robert M. Jotte, Federico Cappuzzo, Denis Moro-Sibilot, Shengchun Kong, Martin Reck, Delvys Rodriguez-Abreu, Fabrice Barlesi, Mark McCleland, Naoyuki Nogami, Wei Zou
Publikováno v:
Journal of Thoracic Oncology. 16:1909-1924
Introduction We report the final overall survival (OS) analyses of atezolizumab-carboplatin-paclitaxel (ACP [experimental arm]) and OS data with approximately 39.8 months of median follow-up with atezolizumab-bevacizumab-carboplatin-paclitaxel (ABCP)
Autor:
Namrata Patil, Raymond Meng, Robert Johnston, Patrick Chang, Shyam Srivats, Yoonha Choi, Xiangnan Guan, Barzin Nabet, Lisa McGinnis, Eugene Chiang, Thinh Pham, Alexis Dunkle, Bill O’Gorman, Ira Mellman, Ruozhen Hu, John Silva, Joy Han, Amelia Au-Yeung, Chikara Takahashi, Nandini Molden, Pallavi Daggumati, Wendy Connolly, Melissa Johnson, Delvys Rodriguez Abreu, Byoung Chul Cho, Antoine Italiano, Ignacio Gil Bazo, Enriqueta Felip, Sanjeev Mariathasan, Carlos Bais, David Shames
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Rodolfo Chicas-Sett, Juan Zafra-Martin, Ignacio Morales-Orue, Juan Castilla-Martinez, Miguel A. Berenguer-Frances, Elisa Gonzalez-Rodriguez, Delvys Rodriguez-Abreu, Felipe Couñago
Publikováno v:
Cancers, Vol 12, Iss 8, p 2178 (2020)
Lung cancer is one of the main causes of cancer-related mortality worldwide. Over the years, different therapeutic modalities have been adopted depending on tumor stage and patient characteristics, such as surgery, radiotherapy (RT), and chemotherapy
Externí odkaz:
https://doaj.org/article/6c73751766dd45dd915758fe800088fb